26 October 2021: Clinical Research
Expression of Interleukin-17, Tumor Necrosis Factor-Alpha, and Matrix Metalloproteinase-8 in Patients with Chronic Peri-Implant Mucositis
Darius Gleiznys 1ABCDEFG* , Albertas Kriauciunas 1BCDE , Julius Maminskas 1AB , Arturas Stumbras 2FG , Dalia Giedrimiene 3CD , Christine Niekrash 4CDE , Alvydas Gleiznys 1AD , Jurgina Sakalauskiene 1ABEF , Astra Vitkauskiene 5ACDEDOI: 10.12659/MSM.932243
Med Sci Monit 2021; 27:e932243
Table 4 Differences in bacteria A. actinomycetemcomitans (A. a.), P. gingivalis (P. g.), T. denticola (T. d.), F. nucleatum (F.), P. intermedia (P. i.), T. forsythia (T. f.), P. micra (P.m.), C. rectus (C. r.), E. nodatum (E. n.), E. corrodens (E. c.), C. sputigenal (C. s.) frequencies in the study group patients.
| Bacteria | Study groups | χ2, df=2, P | ||
|---|---|---|---|---|
| HP, n=30 | MP, n=30 | TP, n=30 | ||
| % | ||||
| Aggregatibacter actinomycetemcomitans (A.a.) | 0 | 30.0 | 26.7 | 10.588; 0.005P |
| Porphyromonas gingivalis (P.g.) | 0 | 46.7 | 43.3 | 19.365; |
| Prevotella intermedia (P.i.) | 3.3 | 13.3 | 10.0 | 1.921; 0.383 |
| Tannerella forsythia (T.f.) | 0 | 20.0 | 16.7 | 6.421; 0.04P |
| Treponema denticola (T.d.) | 0 | 43.3 | 36.7 | 16.705; |
| Parvimonas micra (P.m.) | 0 | 60.0 | 56.7 | 28.706; |
| Fusobacterium nucleatum/periodonticum (F.n.) | 3.3 | 100.0 | 50.0 | 56.117; |
| Campylobacter rectus (C.r.) | 6.7 | 26.7 | 13.3 | 4.737; 0.094 |
| Eubacterium nodatum (E.n.) | 10.0 | 20.0 | 16.7 | 1.184; 0.553 |
| Eikenella corrodens (E.c.) | 16.7 | 53.3 | 46.7 | 9.631; 0.008P |
| Capnocytophaga spp. (C.s.) | 3.3 | 80.0 | 66.7 | 40.267; |
| χ – Chi square test; df – degrees of freedom; HP – healthy subjects; MP – patients with untreated peri-implant mucositis; TP – patients treated with mechanical anti-infective therapies for mucositis. | ||||